as on February 13, 2026 at 9:31 pm IST
Day's Low
Day's High
0.66%
Downside
3.45%
Upside
52 Week's Low
52 Week's High
11.77%
Downside
59.59%
Upside
as on February 13, 2026 at 4:01 pm IST
Market Cap
₹3,162.94 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
26.65
Return on capital employed (ROCE)
0Industry PE ratio
41.52
Beta (LTM)
1.56
P/B Ratio
0.85
Dividend Yield
0PEG Ratio
1.83
Quarterly Earnings Growth YOY
-380.13
EPS (TTM)
0.21
Sector
Pharmaceuticals
Book Value
371.91
Technical Analysis
Bearish
View Technical Analysis
as on February 13, 2026 at 4:01 pm IST
Dishman Carbogen in the last 5 years
Lowest (-599.35x)
March 22, 2023
Today (26.65x)
February 13, 2026
Industry (41.52x)
February 13, 2026
Highest (1374.29x)
June 11, 2025
Today’s Price to Earnings Ratio: 26.65x
Compare market cap, revenue, PE, and other key metrics of Dishman Carbogen with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 3,162.94 | 12.74% | 0.68 | 3 | 2,711 | |
| NA | 994.01 | 73.61% | 0.62 | 17 | 177 | |
| NA | 879.25 | -12.31% | 0.60 | 70 | 488 | |
| NA | 11.97 | NA | 0.00 | -3 | 28 | |
| BUY | 14,544.09 | 1.36% | 0.71 | 836 | 7,234 |
Get share price movements and forecasts by analysts on Dishman Carbogen.
Source: S&P Global Market Intelligence
Search interest for Dishman Carbogen Amcis Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Dishman Carbogen.
Dishman Carbogen Amcis Ltd’s net profit fell -380.13% since last year same period to ₹-12.97Cr in the Q3 2025-2026. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated -119.87% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 per share on 15 May 2019 - translating a dividend yield of 0.10%.
Read More about DividendsCheck stock indices that include Dishman Carbogen.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 31.23% to 31.75% in Dec 2025 quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 660.76 Cr → 726.46 Cr (in ₹), with an average increase of 9.0% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 59.32% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 35.3% return, outperforming this stock by 36.0%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 169.5% return, outperforming this stock by 69.7%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 65.27 Cr → -12.97 Cr (in ₹), with an average decrease of 119.9% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 8.07% to 7.66% in Dec 2025 quarter
Price Dip
![]()
In the last 1 month, DCAL stock has moved down by -20.6%
| Organisation | Dishman Carbogen Amcis Ltd |
| Headquarters | Gujarat |
| Industry | Pharmaceuticals |
| CEO | Janmejay R Vyas |
| E-voting on shares | Click here to vote |
Dishman Carbogen share price today stands at ₹201.74 as on at the close of the market. Dishman Carbogen share today touched a day high of ₹208.7 and a low of ₹200.4.
Dishman Carbogen touched a 52 week high of ₹321.95 and a 52 week low of ₹178. Dishman Carbogen share price today i.e. is closed at ₹201.74, which is -37.34% down from its 52 week high and 13.34% up from its 52 week low.
Dishman Carbogen market capitalisation is ₹3,162.94 Cr as on .
To buy Dishman Carbogen shares, you need to follow these steps:
Dishman Carbogen trading volume is 1.82L as on . This means that 1.82L shares of Dishman Carbogen were bought and sold on the stock market during today's trading session.